About Us

About Us

About Us Aligos is discovering and developing new classes of molecules that interact directly with disease-causing modalities such as viral encoded proteins and nucleic acids, as well as oncogenes and their resultant proteins in the case of our...
Company Mission

Company Mission

Curative Therapies Duis ligula libero lacinia Company Mission To become a world leader in the development of targeted, curative therapies for hepatologic diseases and viral infections including chronic hepatitis B (CHB), non-alcoholic steatohepatitis...
Contact

Contact

Aligos’ Locations US Office European Office 1 Corporate Dr., 2nd Floor San Francisco, CA 94080 info@aligos.com Gaston Geenslaan 1 / (building 3) 3001 Leuven, Belgium info@aligos.com Google...

Home

Our Mission Aligo aims to become a world leader in the development of targeted, curative treatments for hepatologic diseases and viral infections, including chronic hepatitis B (CHB), nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma...
Investors

Investors

Working out of Copenhagen, with affiliates in San Francisco and Boston, Novo Holdings is a world-leading life science investor with a focus on creating long-term value. The Roche Venture Fund invests in early stage biotech, digital...
Management Team

Management Team

Management Team Board of Directors Management Team Lawrence Blatt, Ph.D., MBA Chief Executive Officer Global Infectious Diseases Therapeutic Area Head – Janssen Co-Founder, Chief Executive Officer – Alios BioPharma C...
Partners

Partners

In June 2018, Aligos entered into an agreement with Emory University whereby Aligos acquired from Emory an exclusive license to technology with respect to a novel class of non-nucleoside class-II capsid assembly modulators. The underlying technology...
Platform & Pipeline

Platform & Pipeline

With Aligos’ extensive expertise and experience in developing therapeutics for chronic liver diseases, we are building a robust pipeline of best-in-class drug candidates focused on developing curative therapies for chronic Hepatitis B and delivering t...
Press & Publications

Press & Publications

Sed in bibendum velit. Suspendisse ullamcorper sapien orci San Joe, June 21, 2018 – Donec gravida dui et sagittis elementum. Sed in bibendum velit. Suspendisse ullamcorper sapien orci, tempus luctus magna lobortis sed. Sed orci erat, euismod vel d...

Privacy Policy

Privacy Policy Who we are Our website address is: http://localhost/aligos. What personal data we collect and why we collect it Comments When visitors leave comments on the site we collect the data shown in the comments form, and also the visitor’s I...